Suchergebnisse - "Tanaka, Yoshimasa"

PubPharm (6)

1

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5-included SARS-CoV-2 variants than homologous vaccination of mRNA vaccine

enthalten in: MedComm | 2023

von Peng, D. | Zhao, T. | Hong, W. | +20

2

A self-assembled trimeric protein vaccine induces protective immunity against Omicron variant

enthalten in: Nature communications | 2022

von He, C. | Yang, J. | Hong, W. | +37

3

Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2021

von Awadasseid, A. | Wu, Y. | Tanaka, Y. | +1

4

Current advances in the development of SARS-CoV-2 vaccines

enthalten in: International journal of biological sciences | 2021

von Awadasseid, A. | Wu, Y. | Tanaka, Y. | +1

5

SARS-CoV-2 variants evolved during the early stage of the pandemic and effects of mutations on adaptation in Wuhan populations

enthalten in: International journal of biological sciences | 2021

von Awadasseid, A. | Wu, Y. | Tanaka, Y. | +1

6

Initial success in the identification and management of the coronavirus disease 2019 (COVID-19) indicates human-to-human transmission in Wuhan, China

enthalten in: International journal of biological sciences | 2020

von Awadasseid, A. | Wu, Y. | Tanaka, Y. | +1

1
[1]